Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

The FDA approved a subcutaneous injection version of Bristol Myers Squibb nivolumab and hyaluronidase-nvhy for the treatment of several cancers including melanoma, non-small cell lung cancer and renal ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

Initially the hair spray brand was a voluntarily recalled by CRLAB USA, based in California, on Dec. 12 and became a Class II ...

BLAIR COUNTY, Pa (WJAC) — The U.S. Food and Drug Administration (FDA) has issued a temporary recall of the latest Gardners ...

Researchers from John Hopkins University and Stanford University built a training model using video recordings of ...

In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has some history on its ... Read ...

Bottle water brands market their product as being pure and natural ... but that's not always the case, as explained in this ...

Core offers FDA-approved nVNS devices with growth potential in healthcare and military markets. Click here to find out what ...

Unfortunately seasonings that contain gluten don't come with a menacing image of wheat. Here's a useful way to figure out if ...

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.